← All trials
NCT06326684
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 7, 2024
- Primary completion
- Mar 15, 2027
- Completion date
- Mar 15, 2027
- First posted
- Mar 22, 2024
- Last posted
- Jun 10, 2024
- Enrollment
- 30
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of KentuckyLead sponsor
- University of KentuckySponsor investigator
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)Collaborator
- University of KentuckyOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.